The REMS publication paradox

Oncology (Williston Park). 2009 Jul;23(8):715-7.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Carrier Proteins / therapeutic use*
  • Humans
  • Publications
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • Risk Management / methods*
  • Thrombopoietin
  • United States
  • United States Food and Drug Administration

Substances

  • Carrier Proteins
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim